Fang Xiang

Director/Board Member en Hrain Biotechnology Co., Ltd. .

45 años

Consumer Services

Health Technology

Perfil

Fang Xiang is currently a Member-Supervisory Board & Medical Director at Hrain Biotechnology Co., Ltd.
His education includes a graduate degree from Wuhan University in 2004.

Cargos activos de Fang Xiang

Empresas	Cargo	Inicio
Hrain Biotechnology Co., Ltd. Hrain Biotechnology Co., Ltd. BiotechnologyHealth Technology Hrain Biotechnology Co., Ltd. engages in the research and development, and production of immune cell therapy products. It offers chimeric antigen receptor (CAR) T-cell therapy, chimeric antigen receptor-transduced natural killer (CAR-NK) cell therapy, dash chimeric antigen receptor (CAR) T-cell therapy. The company was founded by Pin Wang on July 20, 2015 and is headquartered in Shanghai, China.	Director/Board Member	18/06/2021

Todos los cargos activos de Fang Xiang

Formación de Fang Xiang.

Wuhan University

Graduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Fang Xiang.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	1
Hrain Biotechnology Co., Ltd. Hrain Biotechnology Co., Ltd. BiotechnologyHealth Technology Hrain Biotechnology Co., Ltd. engages in the research and development, and production of immune cell therapy products. It offers chimeric antigen receptor (CAR) T-cell therapy, chimeric antigen receptor-transduced natural killer (CAR-NK) cell therapy, dash chimeric antigen receptor (CAR) T-cell therapy. The company was founded by Pin Wang on July 20, 2015 and is headquartered in Shanghai, China.	Health Technology